Clinical Trial Update: Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating eplerenone for chronic central serous chorioretinopathy has completed in the Hungarian population.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Serous Chorioretinopathy

Drugs mentioned

• Inspra (eplerenone)

Snippet

Sponsor: Semmelweis University | Conditions: Chronic Central Serous Chorioretinopathy | Phase 4 | Status: COMPLETED